{"title":"武汉地区新冠肺炎患者嗅觉和味觉功能障碍","authors":"Li Zou, Tingyan Yu, Yangyang Zhang, Li-xiang Dai, Zhaohui Zhang, Zhentao Zhang","doi":"10.21203/rs.3.rs-28370/v1","DOIUrl":null,"url":null,"abstract":"\n Background: The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 isspreading all over the world.The main symptoms of COVID-19 include fever, cough,fatigue, and myalgia. However, there are few reports onolfactoryand gustatory dysfunctions in patients with COVID-19.Objective: To investigate the incidence of olfactory and gustatory dysfunctions in patients with confirmed COVID-19 infection, in Wuhan, China.Methods:In this retrospective study,we collected 81 confirmed cases of COVID-19 from the Renmin Hospital of Wuhan University, from February 2020 to March 2020, and analyzed the demographic characteristics, clinical manifestations (including olfactory and gustatory dysfunctions), laboratory findings,and comorbidities.Results: A total of 81 confirmed COVID-19 patients were enrolledin this study (38 males). The most prevalent symptoms include cough, myalgia, and loss of appetite. On admission, 25 (30.9%) of all patients reported either olfactory dysfunction (OD) or gustatory dysfunction (GD), and 7 (8.6%) reported both OD and GD. 13.6% and 25.9% of allpatients reported OD and GD, respectively. OD and GD were not associated with disease severity. Pearson correlation analysisidentified some factors are positively correlated with OD and GD, including headache or dizziness (r = 0.342, P = 0.002), dark urine (r = 0.256, P = 0.021), IgM titer (r = 0.305, P = 0.01), and diabetes (r = 0.275, P = 0.013). In 81.8% of the cases with OD and 28.6% of the cases with GD, the symptomslasted for at least 1 month after discharge.3.6% of inpatients without OD developed OD after discharge.Conclusion:OD and GDare common in COVID-19.These symptoms appear early during thecourse of disease, and may last for at least 1 month.The incidence of OD and GDisrelated to neurological manifestations, diabetics, and IgM titers.","PeriodicalId":93251,"journal":{"name":"Ageing and neurodegenerative diseases","volume":"111 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Olfactory and Gustatory Dysfunctions in Patients With COVID-19 in Wuhan, China\",\"authors\":\"Li Zou, Tingyan Yu, Yangyang Zhang, Li-xiang Dai, Zhaohui Zhang, Zhentao Zhang\",\"doi\":\"10.21203/rs.3.rs-28370/v1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Background: The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 isspreading all over the world.The main symptoms of COVID-19 include fever, cough,fatigue, and myalgia. However, there are few reports onolfactoryand gustatory dysfunctions in patients with COVID-19.Objective: To investigate the incidence of olfactory and gustatory dysfunctions in patients with confirmed COVID-19 infection, in Wuhan, China.Methods:In this retrospective study,we collected 81 confirmed cases of COVID-19 from the Renmin Hospital of Wuhan University, from February 2020 to March 2020, and analyzed the demographic characteristics, clinical manifestations (including olfactory and gustatory dysfunctions), laboratory findings,and comorbidities.Results: A total of 81 confirmed COVID-19 patients were enrolledin this study (38 males). The most prevalent symptoms include cough, myalgia, and loss of appetite. On admission, 25 (30.9%) of all patients reported either olfactory dysfunction (OD) or gustatory dysfunction (GD), and 7 (8.6%) reported both OD and GD. 13.6% and 25.9% of allpatients reported OD and GD, respectively. OD and GD were not associated with disease severity. Pearson correlation analysisidentified some factors are positively correlated with OD and GD, including headache or dizziness (r = 0.342, P = 0.002), dark urine (r = 0.256, P = 0.021), IgM titer (r = 0.305, P = 0.01), and diabetes (r = 0.275, P = 0.013). In 81.8% of the cases with OD and 28.6% of the cases with GD, the symptomslasted for at least 1 month after discharge.3.6% of inpatients without OD developed OD after discharge.Conclusion:OD and GDare common in COVID-19.These symptoms appear early during thecourse of disease, and may last for at least 1 month.The incidence of OD and GDisrelated to neurological manifestations, diabetics, and IgM titers.\",\"PeriodicalId\":93251,\"journal\":{\"name\":\"Ageing and neurodegenerative diseases\",\"volume\":\"111 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ageing and neurodegenerative diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21203/rs.3.rs-28370/v1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ageing and neurodegenerative diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21203/rs.3.rs-28370/v1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
摘要
背景:由SARS-CoV-2引起的冠状病毒病2019 (COVID-19)正在全球蔓延。新冠肺炎的主要症状包括发烧、咳嗽、疲劳和肌痛。然而,关于COVID-19患者嗅觉和味觉功能障碍的报道很少。目的:了解武汉市新冠肺炎确诊患者嗅觉和味觉功能障碍的发生率。方法:回顾性分析武汉大学人民医院2020年2月至2020年3月收治的新冠肺炎确诊病例81例,分析其人口学特征、临床表现(包括嗅觉和味觉功能障碍)、实验室检查结果及合并症。结果:本研究共纳入新冠肺炎确诊患者81例(男性38例)。最常见的症状包括咳嗽、肌痛和食欲不振。入院时,25例(30.9%)患者报告嗅觉功能障碍(OD)或味觉功能障碍(GD), 7例(8.6%)患者报告OD和GD。13.6%和25.9%的患者分别报告了OD和GD。OD和GD与疾病严重程度无关。Pearson相关分析发现,头痛或头晕(r = 0.342, P = 0.002)、尿色深(r = 0.256, P = 0.021)、IgM滴度(r = 0.305, P = 0.01)、糖尿病(r = 0.275, P = 0.013)与OD和GD呈正相关。81.8%的OD和28.6%的GD患者在出院后症状持续至少1个月,3.6%的住院无OD患者在出院后出现OD。结论:OD和GDare在COVID-19中常见。这些症状出现在病程早期,并可能持续至少1个月。OD和gd的发生率与神经系统表现、糖尿病和IgM滴度无关。
Olfactory and Gustatory Dysfunctions in Patients With COVID-19 in Wuhan, China
Background: The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 isspreading all over the world.The main symptoms of COVID-19 include fever, cough,fatigue, and myalgia. However, there are few reports onolfactoryand gustatory dysfunctions in patients with COVID-19.Objective: To investigate the incidence of olfactory and gustatory dysfunctions in patients with confirmed COVID-19 infection, in Wuhan, China.Methods:In this retrospective study,we collected 81 confirmed cases of COVID-19 from the Renmin Hospital of Wuhan University, from February 2020 to March 2020, and analyzed the demographic characteristics, clinical manifestations (including olfactory and gustatory dysfunctions), laboratory findings,and comorbidities.Results: A total of 81 confirmed COVID-19 patients were enrolledin this study (38 males). The most prevalent symptoms include cough, myalgia, and loss of appetite. On admission, 25 (30.9%) of all patients reported either olfactory dysfunction (OD) or gustatory dysfunction (GD), and 7 (8.6%) reported both OD and GD. 13.6% and 25.9% of allpatients reported OD and GD, respectively. OD and GD were not associated with disease severity. Pearson correlation analysisidentified some factors are positively correlated with OD and GD, including headache or dizziness (r = 0.342, P = 0.002), dark urine (r = 0.256, P = 0.021), IgM titer (r = 0.305, P = 0.01), and diabetes (r = 0.275, P = 0.013). In 81.8% of the cases with OD and 28.6% of the cases with GD, the symptomslasted for at least 1 month after discharge.3.6% of inpatients without OD developed OD after discharge.Conclusion:OD and GDare common in COVID-19.These symptoms appear early during thecourse of disease, and may last for at least 1 month.The incidence of OD and GDisrelated to neurological manifestations, diabetics, and IgM titers.